-
-
-
-
-
-
-
RedHill Announces New USPTO Patent Covering Talicia® Through 2034
-
-
-
-
-
-
-
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia with IP Protection Running to 2034
-
-
-
-
-
-
-
RedHill Biopharma (RDHL) Announces FDA sNDA Approval for Talicia
-
-
-
-
-
-
-
RedHill Biopharma's (RDHL) RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial
-
-
-
-
-
-
-
RedHill Biopharma Announces Q1/2023 Financial Results and Operational Highlights
-
-
-
-
-
-
-
RedHill's RHB-102 (BEKINDA®) and Opaganib Granted New Patents in Oncology Setting
-
923,760 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All